Cite
HARVARD Citation
Kim, P. et al. (n.d.). 1083. Phase 1b Results of Pharmacokinetics, Pharmacodynamics, and Safety for LBP-EC01, a CRISPR-Cas3 Enhanced Bacteriophage Cocktail Targeting Escherichia coli that Cause Urinary Tract Infections. Open forum infectious diseases. p. S633. [Online].